Bernotas
Ronald Charles Bernotas, Wayne, PA US
Patent application number | Description | Published |
---|---|---|
20090069373 | Quinoline Acids - This invention relates generally to quinoline-based modulators of Liver X receptors (LXRs) and related methods. | 03-12-2009 |
20100184786 | Polar Quinazolines - Disclosed are polar quinazoline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): | 07-22-2010 |
20110034526 | Benzimidazole Compounds - This invention relates generally to benzimidazole-based modulators of Liver X receptors (LXRs) having formula (I) and related methods: | 02-10-2011 |
20110112135 | Imidazo [1,2-A] Pyridine Compounds - This invention relates generally to imidazo[1,2-a]pyridine-based modulators of Liver X receptors (LXRs) having formula (I) and related methods: | 05-12-2011 |
20120010205 | NOVEL QUINOLINE ESTERS USEFUL FOR TREATING SKIN DISORDERS - Disclosed are quinoline esters of Formula (I): | 01-12-2012 |
Ronald Charles Bernotas, Royersford, PA US
Patent application number | Description | Published |
---|---|---|
20090253711 | HETEROCYCLYL-3-SULFONYLINDAZOLES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS - The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor. | 10-08-2009 |
20100273816 | Quinazoline Compounds - Disclosed are quinazoline-based modulators of Liver X receptors (LXRs) and related methods. The modulators include compounds of formula (I): | 10-28-2010 |
Ronald Charles Bernotas, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20080306106 | 1-HETEROCYCLYLALKYL-3-SULFONYLAZAINDOLE OR -AZAINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS - The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor. | 12-11-2008 |